184 related articles for article (PubMed ID: 1645569)
1. Modulation of neuroendocrine surface antigens in oncogene-activated small cell lung cancer lines.
Doyle LA; Mabry M; Stahel RA; Waibel R; Goldstein LH
Br J Cancer Suppl; 1991 Jun; 14():39-42. PubMed ID: 1645569
[TBL] [Abstract][Full Text] [Related]
2. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
[TBL] [Abstract][Full Text] [Related]
3. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.
Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T
Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905
[TBL] [Abstract][Full Text] [Related]
4. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
van Waardenburg RC; Meijer C; Pinto-Sietsma SJ; de Vries EG; Timens W; Mulder NM
Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061
[TBL] [Abstract][Full Text] [Related]
5. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
[TBL] [Abstract][Full Text] [Related]
6. The growth inhibitory effect of N1,N12-bis(ethyl)spermine in small cell lung cancer cells is maintained in cells expressing the c-myc and Ha-ras oncogenes.
Barr LF; Campbell SE; Tamez P; Casero RA
Clin Cancer Res; 1998 Jun; 4(6):1557-61. PubMed ID: 9626477
[TBL] [Abstract][Full Text] [Related]
7. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.
Barr LF; Campbell SE; Bochner BS; Dang CV
Cancer Res; 1998 Dec; 58(23):5537-45. PubMed ID: 9850091
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid.
Doyle LA; Giangiulo D; Hussain A; Park HJ; Yen RW; Borges M
Cancer Res; 1989 Dec; 49(23):6745-51. PubMed ID: 2555051
[TBL] [Abstract][Full Text] [Related]
9. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF
Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes.
Waibel R; Mannhart M; O'Hara CJ; Brocklehurst C; Zangemeister-Wittke U; Schenker T; Lehmann HP; Weber E; Stahel RA
Cancer Res; 1993 Jun; 53(12):2840-5. PubMed ID: 7684948
[TBL] [Abstract][Full Text] [Related]
11. Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line.
Watanabe H; Takahashi T; Ueda R; Utsumi KR; Sato T; Ariyoshi Y; Ota K; Obata Y; Takahashi T
Cancer Res; 1988 May; 48(9):2544-9. PubMed ID: 2833350
[TBL] [Abstract][Full Text] [Related]
12. Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells.
Doyle LA; Cuttitta F; Mulshine JL; Bunn PA; Minna JD
Cancer Res; 1987 Oct; 47(19):5009-13. PubMed ID: 3040237
[TBL] [Abstract][Full Text] [Related]
13. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer.
Kalemkerian GP; Jasti RK; Celano P; Nelkin BD; Mabry M
Cell Growth Differ; 1994 Jan; 5(1):55-60. PubMed ID: 8123593
[TBL] [Abstract][Full Text] [Related]
14. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35.
Takahashi T; Ueda R; Song X; Nishida K; Shinzato M; Namikawa R; Ariyoshi Y; Ota K; Kato K; Nagatsu T
Cancer Res; 1986 Sep; 46(9):4770-5. PubMed ID: 3015397
[TBL] [Abstract][Full Text] [Related]
15. Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies.
Rosen ST; Mulshine JL; Cuttitta F; Fedorko J; Carney DN; Gazdar AF; Minna JD
Cancer Res; 1984 May; 44(5):2052-61. PubMed ID: 6713399
[TBL] [Abstract][Full Text] [Related]
16. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrate.
Hay FG; Duncan LW; Langdon SP; Leonard RC
Br J Cancer Suppl; 1991 Jun; 14():33-5. PubMed ID: 1645568
[TBL] [Abstract][Full Text] [Related]
19. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
20. Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis.
Myklebust AT; Beiske K; Pharo A; Davies CD; Aamdal S; Fodstad O
Br J Cancer Suppl; 1991 Jun; 14():49-53. PubMed ID: 1645572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]